2016-2020 US Hepatitis Diagnostic Testing Market: Emerging Opportunities and Growth Strategies for Suppliers
![](/report_cover/2215/2016-2020-us-hepatitis-diagnostic-testing-market-emerging_en.gif)
Complete report $3,900. DataPack (test volumes, sales forecasts, supplier shares) $2,500. The report presents a detailed analysis of the Hepatitis diagnostics market in the US.
Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:
Contains 241 pages and 14 tables
Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:
- Hospitals
- Commercial/Private Labs
- Blood Banks
- Physician Offices
- Public Health Labs
Contains 241 pages and 14 tables
I. INTRODUCTION
II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Major Routine and Special Coagulation Tests
1. Introduction
2. Activated Partial Thromboplastin Time (APTT)
3. Alpha-2 Antiplasmin
4. Antithrombin III
5. Bleeding Time
6. D-Dimer
7. Ethanol Flocculation Test
8. Euglobulin Lysis
9. Factor Assays
a. Introduction
b. Factor II
c. Factor V/Factor V Leiden
d. Factor VII
e. Factor VIII
f. Factor IX
g. Factor IXa
h. Factor X (Stuart Factor)
i. Factor Xa
j. Factor XI
k. Factor XII
l. Factor XIII
10. Fibrin Degradation Products
11. Fibrinogen
12. Heparin
13. Hirudin
14. Hypercoagulability and Thrombosis
15. Lipoprotein a
16. Plasmin
17. Plasminogen
18. Plasminogen Activator Inhibitor (PAI)
19. Platelet Function Tests
20. Platelet Aggregation
21. Proteins C and S
22. Prothrombin Fragment 1.2
23. Prothrombin Time (PT)
24. Reptilase Time
25. Thrombin Time
26. Tissue-Type Plasminogen Activator (t-PA)
27. Von Willebrand's Factor
B. Instrumentation Review
C. Major in Vitro Diagnostic Technologies and Their Potential Applications
1. Chromogenic Substrates
2. Monoclonal and Polyclonal Antibodies
3. Immunoassays
4. Molecular Diagnostics
5. Microcomputers
6. Automation
7. Robotics
8. Artificial Intelligence
9. Dry Chemistry
10. Biosensors
III. U.S.A.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Instrument and Reagent Suppliers’ Sales and Market Shares
X. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
XI. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
XII. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types Of Distributors
7. Market Segmentation
XIII. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XIV. COMPETITIVE ASSESSMENTS
Abbott
ADI/American Diagnostic
Axis-Shield
Alere/Biosite/Inverness
Beckman Coulter/Danaher
Becton Dickinson
Bio/Data Corporation
Chrono-Log
Corgenix Medical
Diagnostica Stago/Trinity Biotech
Helena Laboratories
HYPEN BioMed
Instrumentation Laboratory
ITC
Roche
Siemens
Sienco
Sysmex
Thermo Fischer
ZyCare/Alere
II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Major Routine and Special Coagulation Tests
1. Introduction
2. Activated Partial Thromboplastin Time (APTT)
3. Alpha-2 Antiplasmin
4. Antithrombin III
5. Bleeding Time
6. D-Dimer
7. Ethanol Flocculation Test
8. Euglobulin Lysis
9. Factor Assays
a. Introduction
b. Factor II
c. Factor V/Factor V Leiden
d. Factor VII
e. Factor VIII
f. Factor IX
g. Factor IXa
h. Factor X (Stuart Factor)
i. Factor Xa
j. Factor XI
k. Factor XII
l. Factor XIII
10. Fibrin Degradation Products
11. Fibrinogen
12. Heparin
13. Hirudin
14. Hypercoagulability and Thrombosis
15. Lipoprotein a
16. Plasmin
17. Plasminogen
18. Plasminogen Activator Inhibitor (PAI)
19. Platelet Function Tests
20. Platelet Aggregation
21. Proteins C and S
22. Prothrombin Fragment 1.2
23. Prothrombin Time (PT)
24. Reptilase Time
25. Thrombin Time
26. Tissue-Type Plasminogen Activator (t-PA)
27. Von Willebrand's Factor
B. Instrumentation Review
C. Major in Vitro Diagnostic Technologies and Their Potential Applications
1. Chromogenic Substrates
2. Monoclonal and Polyclonal Antibodies
3. Immunoassays
4. Molecular Diagnostics
5. Microcomputers
6. Automation
7. Robotics
8. Artificial Intelligence
9. Dry Chemistry
10. Biosensors
III. U.S.A.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Instrument and Reagent Suppliers’ Sales and Market Shares
X. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
XI. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
XII. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types Of Distributors
7. Market Segmentation
XIII. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XIV. COMPETITIVE ASSESSMENTS
Abbott
ADI/American Diagnostic
Axis-Shield
Alere/Biosite/Inverness
Beckman Coulter/Danaher
Becton Dickinson
Bio/Data Corporation
Chrono-Log
Corgenix Medical
Diagnostica Stago/Trinity Biotech
Helena Laboratories
HYPEN BioMed
Instrumentation Laboratory
ITC
Roche
Siemens
Sienco
Sysmex
Thermo Fischer
ZyCare/Alere
LIST OF TABLES
Major Companies Developing or Marketing Activated Clotting Time Tests
Major Companies Developing or Marketing APTT Tests
Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
Major Companies Developing or Marketing Antithrombin III Tests
Major Companies Developing or Marketing Bleeding Time Tests
Major Companies Developing or Marketing D-dimer Tests
Major Companies Developing or Marketing Factor Assays
Major Companies Developing or Marketing Fibrin Degradation Product Tests
Major Companies Developing or Marketing Fibrinogen Tests
Major Companies Developing or Marketing Heparin Tests
Major Companies Developing or Marketing Plasmin Tests
Major Companies Developing or Marketing Plasminogen Tests
Major Companies Developing or Marketing Plasminogen Activator Inhibitor Tests
Major Companies Developing or Marketing Platelet Aggregation Tests
Major Companies Developing or Marketing Protein C Tests
Major Companies Developing or Marketing Protein S Tests
Major Companies Developing or Marketing PT Tests
Major Companies Developing or Marketing Thrombin Time Tests
Major Companies Developing or Marketing TPA Tests
Major Companies Developing or Marketing Von Willebrand's Factor Tests
Executive Summary Table: U.S.A., Total Coagulation Diagnostics Market By Market Segment and Product Category
U.S.A., Laboratories Performing Coagulation Tests By Market Segment
U.S.A., Hospital Laboratories Performing Coagulation Tests By Bed Size
U.S.A., Commercial/Private Laboratories Performing Coagulation Tests By Annual Test Volume
U.S.A., Hospital Laboratories Average Daily Test Volume
U.S.A., Commercial/Private Laboratories Average Daily Test Volume
U.S.A., Physician Offices/Group Practices Average Daily Test Volume
U.S.A., Total Coagulation Test Volume By Market Segment
U.S.A., All Market Segments Coagulation Test Volume
U.S.A., Hospital Laboratories Coagulation Test Volume
U.S.A., Commercial/Private Laboratories Coagulation Test Volume
U.S.A., Physician Offices/Group Practices Coagulation Test Volume
U.S.A., Coagulation Reagent Market By Market Segment
U.S.A., Major Suppliers of Coagulation Reagents Estimated Sales and Market Shares
U.S.A., Coagulation Instrument Market By Market Segment
U.S.A., Major Suppliers of Coagulation Analyzers, Estimated Instrument Sales and Market Shares
U.S.A., Total Coagulation Diagnostics Market By Product Category
U.S.A., Major Suppliers of Coagulation Diagnostic Products, Estimated Sales and Market Shares
Major Companies Developing or Marketing Activated Clotting Time Tests
Major Companies Developing or Marketing APTT Tests
Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
Major Companies Developing or Marketing Antithrombin III Tests
Major Companies Developing or Marketing Bleeding Time Tests
Major Companies Developing or Marketing D-dimer Tests
Major Companies Developing or Marketing Factor Assays
Major Companies Developing or Marketing Fibrin Degradation Product Tests
Major Companies Developing or Marketing Fibrinogen Tests
Major Companies Developing or Marketing Heparin Tests
Major Companies Developing or Marketing Plasmin Tests
Major Companies Developing or Marketing Plasminogen Tests
Major Companies Developing or Marketing Plasminogen Activator Inhibitor Tests
Major Companies Developing or Marketing Platelet Aggregation Tests
Major Companies Developing or Marketing Protein C Tests
Major Companies Developing or Marketing Protein S Tests
Major Companies Developing or Marketing PT Tests
Major Companies Developing or Marketing Thrombin Time Tests
Major Companies Developing or Marketing TPA Tests
Major Companies Developing or Marketing Von Willebrand's Factor Tests
Executive Summary Table: U.S.A., Total Coagulation Diagnostics Market By Market Segment and Product Category
U.S.A., Laboratories Performing Coagulation Tests By Market Segment
U.S.A., Hospital Laboratories Performing Coagulation Tests By Bed Size
U.S.A., Commercial/Private Laboratories Performing Coagulation Tests By Annual Test Volume
U.S.A., Hospital Laboratories Average Daily Test Volume
U.S.A., Commercial/Private Laboratories Average Daily Test Volume
U.S.A., Physician Offices/Group Practices Average Daily Test Volume
U.S.A., Total Coagulation Test Volume By Market Segment
U.S.A., All Market Segments Coagulation Test Volume
U.S.A., Hospital Laboratories Coagulation Test Volume
U.S.A., Commercial/Private Laboratories Coagulation Test Volume
U.S.A., Physician Offices/Group Practices Coagulation Test Volume
U.S.A., Coagulation Reagent Market By Market Segment
U.S.A., Major Suppliers of Coagulation Reagents Estimated Sales and Market Shares
U.S.A., Coagulation Instrument Market By Market Segment
U.S.A., Major Suppliers of Coagulation Analyzers, Estimated Instrument Sales and Market Shares
U.S.A., Total Coagulation Diagnostics Market By Product Category
U.S.A., Major Suppliers of Coagulation Diagnostic Products, Estimated Sales and Market Shares